319 related articles for article (PubMed ID: 30695679)
1. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone.
Oaks Z; Stage A; Middleton B; Faraone S; Johnson B
Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia.
Jackson D; Singh S; Zhang-James Y; Faraone S; Johnson B
Front Psychiatry; 2021; 12():593842. PubMed ID: 33664680
[No Abstract] [Full Text] [Related]
3. Ameliorative response to detoxification, psychotherapy, and medical management in patients maintained on opioids for pain.
Belkin M; Reinheimer HS; Levy J; Johnson B
Am J Addict; 2017 Oct; 26(7):738-743. PubMed ID: 28800186
[TBL] [Abstract][Full Text] [Related]
4. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.
Chu LF; Clark DJ; Angst MS
J Pain; 2006 Jan; 7(1):43-8. PubMed ID: 16414554
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.
Rowbotham MC; Wallace M
J Pain; 2020; 21(9-10):1031-1046. PubMed ID: 32006699
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes.
Trofimovitch D; Baumrucker SJ
Am J Hosp Palliat Care; 2019 Oct; 36(10):907-912. PubMed ID: 30917675
[TBL] [Abstract][Full Text] [Related]
7. Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system.
Johnson B; Ulberg S; Shivale S; Donaldson J; Milczarski B; Faraone SV
Discov Med; 2014 Oct; 18(99):209-20. PubMed ID: 25336035
[TBL] [Abstract][Full Text] [Related]
8. Opioid-Induced Hyperalgesia in the Nonsurgical Setting: A Systematic Review.
Yang DZ; Sin B; Beckhusen J; Xia D; Khaimova R; Iliev I
Am J Ther; 2019; 26(3):e397-e405. PubMed ID: 29726847
[TBL] [Abstract][Full Text] [Related]
9. Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study.
Hina N; Fletcher D; Poindessous-Jazat F; Martinez V
Eur J Anaesthesiol; 2015 Apr; 32(4):255-61. PubMed ID: 25485877
[TBL] [Abstract][Full Text] [Related]
10. Pressure Pain Sensitivity in Patients With Suspected Opioid-Induced Hyperalgesia.
Wasserman RA; Hassett AL; Harte SE; Goesling J; Malinoff HL; Berland DW; Zollars J; Moser SE; Brummett CM
Reg Anesth Pain Med; 2015; 40(6):687-93. PubMed ID: 26469365
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review.
Kim PS; Fishman MA
Curr Pain Headache Rep; 2020 Aug; 24(10):64. PubMed ID: 32845365
[TBL] [Abstract][Full Text] [Related]
12. Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia.
Chen L; Sein M; Vo T; Amhmed S; Zhang Y; Hilaire KS; Houghton M; Mao J
J Opioid Manag; 2014; 10(6):383-93. PubMed ID: 25531956
[TBL] [Abstract][Full Text] [Related]
13. Depression in Fibromyalgia Patients May Require Low-Dose Naltrexone to Respond: A Case Report.
Siembida J; Johnson B
Cureus; 2022 Feb; 14(2):e22677. PubMed ID: 35386139
[TBL] [Abstract][Full Text] [Related]
14. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.
Higgins C; Smith BH; Matthews K
Br J Anaesth; 2019 Jun; 122(6):e114-e126. PubMed ID: 30915985
[TBL] [Abstract][Full Text] [Related]
15. Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.
Arout CA; Waters AJ; MacLean RR; Compton P; Sofuoglu M
Psychopharmacology (Berl); 2019 Oct; 236(10):2857-2866. PubMed ID: 30564869
[TBL] [Abstract][Full Text] [Related]
16. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study.
Younger J; Mackey S
Pain Med; 2009; 10(4):663-72. PubMed ID: 19453963
[TBL] [Abstract][Full Text] [Related]
17. Is opioid-induced hyperalgesia reversible? A study on active and former opioid addicts and drug naïve controls.
Treister R; Eisenberg E; Lawental E; Pud D
J Opioid Manag; 2012; 8(6):343-9. PubMed ID: 23264312
[TBL] [Abstract][Full Text] [Related]
18. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
[TBL] [Abstract][Full Text] [Related]
19. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
Hay JL; White JM; Bochner F; Somogyi AA; Semple TJ; Rounsefell B
J Pain; 2009 Mar; 10(3):316-22. PubMed ID: 19101210
[TBL] [Abstract][Full Text] [Related]
20. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
